# ANI Pharmaceuticals, Inc. (ANIP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ANIP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 503.51M | $ 54.20M | $ 115.04M | $ 330.34M | $ 597.21M |
| 2025 | $ 904.49M | $ 77.67M | $ 131.52M | $ 325.20M | $ 540.72M |
| 2024 | $ 645.76M | $ -19.47M | $ 50.13M | $ 624.09M | $ 428.53M |
| 2023 | $ 526.37M | $ 20.30M | $ 108.61M | $ 285.67M | $ 457.60M |
| 2022 | $ 353.44M | $ -53.50M | $ -53.24M | $ 286.52M | $ 338.54M |
| 2021 | $ 256.91M | $ -50.64M | $ -24.15M | $ 287.37M | $ 358.74M |
| 2020 | $ 265.58M | $ -28.72M | $ -67.59M | $ 185.69M | $ 195.70M |
| 2019 | $ 266.60M | $ 7.63M | $ 22.91M | $ 185.75M | $ 212.79M |
| 2018 | $ 266.22M | $ 20.27M | $ 74.17M | $ 183.02M | $ 197.26M |
| 2017 | $ 238.23M | $ -1.54M | $ -92.38M | $ 201.51M | $ 174.76M |
| 2016 | $ 176.96M | $ 5.37M | $ -167.28M | $ 120.64M | $ 169.65M |
| 2015 | $ 107.16M | $ 21.47M | $ -21.65M | $ 113.43M | $ 160.08M |
| 2014 | $ 79.09M | $ 40.39M | $ -19.39M | $ 110.69M | $ 139.79M |
| 2013 | $ 35.08M | $ -3.23M | $ -8.22M | $ 0 | $ 40.96M |
| 2012 | $ 3.32M | $ -40.02M | $ -37.38M | $ 7.88M | $ 28.18M |
| 2011 | $ 639.3K | $ -75.82M | $ -71.39M | $ 17.34M | $ 37.82M |
| 2010 | $ 3.75M | $ -69.95M | $ -60.81M | $ 18.55M | $ 19.15M |
| 2009 | $ 1.90M | $ -71.96M | $ -28.16M | $ 16.68M | $ 15.83M |
| 2008 | $ 5.70M | $ -26.38M | $ -24.51M | $ 0 | $ 13.83M |
| 2007 | $ 746.6K | $ -11.48M | $ 1.09M | $ 0 | $ 29.73M |
| 2006 | $ 21.86M | $ 4.23M | $ -4.89M | $ 0 | $ 18.07M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.55 |
| Liabilities / Eq | 1.50 |
| Current Ratio | 2.91 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 117.16 |
| Gross Debt / FCF | 11.81 |

## Other views

- [Metrics](https://sponda.capital/en/ANIP.md)
- [Charts](https://sponda.capital/en/ANIP/charts.md)
- [Compare](https://sponda.capital/en/ANIP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.